e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2007 , Vol 15 , Num 2
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
The Early Results of Posterior Subtenon and Intravitreal Triamcinolone Acetonide Injection for Diffuse Diabetic Macular Edema Treatment
Nilüfer BERKER1, Yasemin ÖZDAMAR1, Necati DEMİR2, Tolga BİÇER3, Özlem ASLAN1, Emel SOYKAN1, Seyhan Sonar ÖZKAN4, Jale KARAKAYA5
1S.B. Ankara Ulucanlar Göz Eğitim ve Araştırma Hastanesi, Ankara, Uzm. Dr.
2S.B. Ankara Göz Eğitim ve Araştırma Hastanesi, Ankara, Uzm. Dr.
3Ankara Ulucanlar Göz Eğitim ve Araş. Hast., Ankara, Asist. Dr.
4Ankara Ulucanlar Göz Eğitim ve Araş. Hast., II.Göz Klinik Şef Yard., Ankara, Doç. Dr.
5Hacettepe Üniversitesi, Tıp Fakültesi, Biyoistatistik, A.D., Ankara, Araş. Gör.
Purpose: To evaluate the efficacy of intravitreal and posterior subtenon injection of triamcinolone acetonide (TA) for diffuse diabetic macular edema.
Materials and Methods: Sixteen eyes of 16 patients with diffuse diabetic macular edema were included in this study. Eight of the eyes received 4mg intravitreal injections of TA (group 1 ), while the remaining eight received 40mg posterior subtenon injections of TA (group 2). Visual acuity and intraocular pressure measurements, biomicroscopic anterior segment and fundus examinations were performed during each follow-up visit. The central macular thickness was measured by optical cohorence tomography.before and 1 month after each injection.
Results: The mean age of patients was 56.9±6.9 years (range, 48 to 67 years). The mean duration of diabetes was 15 years. There were no statistically significant difference of central macular thickness between the two groups prior to injections (group 1: 530±105 μm, group 2: 455±98.4 μm, p<0.01). One month after the injections, central macular thickness significantly decreased in both groups (group 1: 334±91.9 μm, group 2: 263±57 μm). Although the decrease was numerically more pronounced in group 2, the difference between the two groups was found statistically insignificant. The visual acuity increase was observed in 50%of the patients and no complications were noted in both groups.
Conclusions: Both intravitreal and posterior subtenon injections of TA were found successful in the treatment of diabetic macular edema, while no statistically significant difference was noted between the efficacy of those two routes of injections.
Keywords : Diabetic macular edema, intravitreal triamcinolone acetonide; posterior subtenon triamcinolone acetonide
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact